Reconstitution of the full transmembrane cadherin-catenin complex.


Journal

Protein expression and purification
ISSN: 1096-0279
Titre abrégé: Protein Expr Purif
Pays: United States
ID NLM: 9101496

Informations de publication

Date de publication:
05 2022
Historique:
received: 14 12 2021
accepted: 13 01 2022
pubmed: 23 1 2022
medline: 8 4 2022
entrez: 22 1 2022
Statut: ppublish

Résumé

The dynamic regulation of epithelial adherens junctions relies on all components of the E-cadherin-catenin complex. Previously, the complexes have been partially reconstituted and composed only of α-catenin, β-catenin, and the E-cadherin cytoplasmic domain. However, p120-catenin and the full-length E-cadherin including the extracellular, transmembrane, and intra-cellular domains are vital to the understanding of the relationship between extracellular adhesion and intracellular signaling. Here, we reconstitute the complete and full-length cadherin-catenin complex, including full-length E-cadherin, α-catenin, β-catenin, and p120-catenin, into nanodiscs. We are able to observe the cadherin in nanodiscs by cryo-EM. We also reconstitute α-catenin, β-catenin, and p120-catenin with the E-cadherin cytoplasmic tail alone in order to analyze the affinities of their binding interactions. We find that p120-catenin does not associate strongly with α- or β-catenin and binds much more transiently to the cadherin cytoplasmic tail than does β-catenin. Overall, this work creates many new possibilities for biochemical studies understanding transmembrane signaling of cadherins and the role of p120-catenin in adhesion activation.

Identifiants

pubmed: 35063654
pii: S1046-5928(22)00013-4
doi: 10.1016/j.pep.2022.106056
pmc: PMC9487826
mid: NIHMS1773899
pii:
doi:

Substances chimiques

Cadherins 0
Catenins 0
Phosphoproteins 0
beta Catenin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106056

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM122467
Pays : United States
Organisme : NIH HHS
ID : S10 OD023476
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Mol Biol Cell. 2012 Jun;23(11):2092-108
pubmed: 22513089
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Elife. 2020 Sep 11;9:
pubmed: 32915141
Nat Rev Mol Cell Biol. 2014 Jun;15(6):397-410
pubmed: 24824068
Cell. 2010 Apr 2;141(1):117-28
pubmed: 20371349
Oncogene. 2018 Aug;37(35):4769-4780
pubmed: 29780167
Annu Rev Biochem. 1990;59:237-52
pubmed: 2197976
Elife. 2018 Nov 09;7:
pubmed: 30412051
Annu Rev Cell Dev Biol. 2014;30:291-315
pubmed: 25062360
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21545-21555
pubmed: 31591245
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5931-5937
pubmed: 32127478
J Cell Biol. 2010 Jun 28;189(7):1107-15
pubmed: 20584916
J Med Genet. 2006 Feb;43(2):138-42
pubmed: 15831593
Genet Test Mol Biomarkers. 2019 Nov;23(11):759-765
pubmed: 31638429
Structure. 2011 Feb 9;19(2):244-56
pubmed: 21300292
Tissue Barriers. 2021 Oct 2;9(4):1940741
pubmed: 34402758
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34272290
Cancer Res. 2008 May 15;68(10):3645-54
pubmed: 18483246
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16872-16881
pubmed: 31371508
Nat Cell Biol. 2000 Sep;2(9):637-44
pubmed: 10980705
Science. 2014 Oct 31;346(6209):1254211
pubmed: 25359979
Mol Biol Cell. 2011 Nov;22(22):4247-55
pubmed: 21937720
Front Med (Lausanne). 2014 Aug 25;1:24
pubmed: 25593900
J Biol Chem. 2015 Aug 28;290(35):21749-61
pubmed: 26175155
Nat Rev Mol Cell Biol. 2005 Aug;6(8):622-34
pubmed: 16025097
Curr Biol. 2013 Jul 22;23(14):R626-33
pubmed: 23885883
J Cell Sci. 1994 Dec;107 ( Pt 12):3655-63
pubmed: 7706414
Nat Struct Mol Biol. 2013 Feb;20(2):188-93
pubmed: 23292143
Curr Biol. 2021 Jul 26;31(14):3017-3027.e7
pubmed: 34019823
Cell. 2005 Dec 2;123(5):903-15
pubmed: 16325583
Nat Struct Mol Biol. 2016 Jun;23(6):481-6
pubmed: 27273631
Mol Cell. 2000 Mar;5(3):533-43
pubmed: 10882138
PLoS One. 2020 Jun 26;15(6):e0235337
pubmed: 32589661
Nature. 2019 Sep;573(7774):439-444
pubmed: 31485072
Elife. 2020 Sep 02;9:
pubmed: 32876051
Commun Biol. 2019 Jun 19;2:218
pubmed: 31240256
PLoS One. 2016 Feb 04;11(2):e0148574
pubmed: 26845024
Mol Biol Cell. 2008 Oct;19(10):4042-50
pubmed: 18632982
Mol Biol Cell. 2016 Nov 1;27(21):3233-3244
pubmed: 27582386

Auteurs

Allison Maker (A)

University of Washington, Department of Biochemistry, 98195, USA; Seattle Children's Research Institute, Center for Developmental Biology and Regenerative Medicine, 98101, USA.

Barry M Gumbiner (BM)

University of Washington, Department of Biochemistry, 98195, USA; Seattle Children's Research Institute, Center for Developmental Biology and Regenerative Medicine, 98101, USA; University of Washington, Department of Pediatrics, USA. Electronic address: gumbiner@uw.edu.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH